DOI QR코드

DOI QR Code

Risk factors for the occurrence and persistence of coronary aneurysms in Kawasaki disease

  • Jeon, Soo-Kyeong (Department of Pediatrics, Pusan National University Children's Hospital) ;
  • Kim, Geena (Department of Pediatrics, Pusan National University Children's Hospital) ;
  • Ko, Hoon (Department of Pediatrics, Pusan National University Children's Hospital) ;
  • Byun, Joung-Hee (Department of Pediatrics, Pusan National University Children's Hospital) ;
  • Lee, Hyoung Doo (Department of Pediatrics, Pusan National University Children's Hospital)
  • 투고 : 2018.09.11
  • 심사 : 2018.11.22
  • 발행 : 2019.04.15

초록

Purpose: Prognostic factors of coronary aneurysms in Kawasaki disease have been investigated in many studies. The aim of this study was to identify risk factors associated with early and late coronary artery outcomes in treated patients with Kawasaki disease. Methods: A total of 392 patients diagnosed with Kawasaki disease from January 2012 to December 2015 in Pusan National University Children's Hospital were retrospectively selected as subjects of the present study to determine risk factors for coronary aneurysms and persistence of coronary aneurysms after a 1-year follow-up. Results: Coronary aneurysms were detected in 30 of 392 patients within 1 month after the occurrence of Kawasaki disease. Coronary aneurysms persisted in 5 of 30 patients after a 1-year follow-up. A long duration of fever (adjusted odds ratio [OR], 1.47; 95% confidence interval [CI], 1.06-2.02; P=0.018) and high platelet count (adjusted OR, 1.00; 95% CI, 1.00-1.01; P=0.009) were found to be independent factors to predict the development of coronary aneurysms in the early phase. Initial coronary severity (adjusted OR, 46.0; 95% CI, 2.01-1047.80; P=0.016) and a high white blood cell count (adjusted OR, 1.17; 95% CI, 1.01-1.36; P=0.028) were found to be significant factors for the persistence of late coronary aneurysms in univariate analysis. However, no significant factors were found in multivariate analysis. Conclusion: These data are from early and late follow-up of coronary aneurysms in our unit. Further studies are needed to determine the mechanisms involved in the disappearance of coronary aneurysms and related factors.

키워드

참고문헌

  1. Lee YH. Kawasaki disease. Yeungnam Univ J Med 2000;17:99-107. https://doi.org/10.12701/yujm.2000.17.2.99
  2. Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:1776-80. https://doi.org/10.1161/01.CIR.87.5.1776
  3. Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr Cardiol 2003;24:122-6. https://doi.org/10.1007/s00246-002-0063-1
  4. Hirata S, Nakamura Y, Yanagawa H. Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr 2001;90:40-4. https://doi.org/10.1111/j.1651-2227.2001.tb00253.x
  5. Lin MT, Sun LC, Wu ET, Wang JK, Lue HC, Wu MH. Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous ${\gamma}$-immunoglobulin therapy. Arch Dis Child 2015;100:542-7. https://doi.org/10.1136/archdischild-2014-306427
  6. Ha KS, Jang G, Lee J, Lee K, Hong Y, Son C, et al. Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis. Eur J Pediatr 2013;172:343-9. https://doi.org/10.1007/s00431-012-1891-5
  7. Kim JJ, Hong YM, Yun SW, Han MK, Lee KY, Song MS, et al. Assessment of risk factors for Korean children with Kawasaki disease. Pediatr Cardiol 2012;33:513-20. https://doi.org/10.1007/s00246-011-0143-1
  8. Park JW, Chung E, Park K, Jang YT, Park SA. Long term follow-up study of patients with Kawasaki disease. Pediatr Infect Vaccine 2015;22:164-71. https://doi.org/10.14776/piv.2015.22.3.164
  9. Kim T, Choi W, Woo CW, Choi B, Lee J, Lee K, et al. Predictive risk factors for coronary artery abnormalities in Kawasaki disease. Eur J Pediatr 2007;166:421-5. https://doi.org/10.1007/s00431-006-0251-8
  10. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114:1708-33. https://doi.org/10.1542/peds.2004-2182
  11. Tewelde H, Yoon J, Van Ittersum W, Worley S, Preminger T, Goldfarb J. The Harada score in the US population of children with Kawasaki disease. Hosp Pediatr 2014;4:233-8. https://doi.org/10.1542/hpeds.2014-0008
  12. Lang B. Recognizing Kawasaki disease. Paediatr Child Health 2001;6:638-43. https://doi.org/10.1093/pch/6.9.638
  13. Burns JC, Kushner HI, Bastian JF, Shike H, Shimizu C, Matsubara T, et al. Kawasaki disease: a brief history. Pediatrics 2000;106:E27. https://doi.org/10.1542/peds.106.2.e27
  14. Jung JW. Long-term outcome of Kawasaki disease complicated by a large coronary aneurysm. Korean Circ J 2017;47:444-5. https://doi.org/10.4070/kcj.2017.0135
  15. Kim GB, Han JW, Park YW, Song MS, Hong YM, Cha SH, et al. Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011. Pediatr Infect Dis J 2014;33:24-7. https://doi.org/10.1097/INF.0000000000000010
  16. Heo MY, Choi SJ, Kim HS, Sohn SJ. Clinical features of atypical Kawasaki disease. J Korean Pediatr Soc 2002;45:376-82.
  17. Lee HY, Song MS. Predictive factors of resistance to intravenous immunoglobulin and coronary artery lesions in Kawasaki disease. Korean J Pediatr 2016;59:477-82. https://doi.org/10.3345/kjp.2016.59.12.477
  18. Ha KS, Jang GY, Lee J, Lee KC, Son CS. Laboratory markers in incomplete Kawasaki disease according to coronary artery outcome. Korean Circ J 2018;48:287-95. https://doi.org/10.4070/kcj.2017.0342
  19. Baek JY, Song MS. Meta-analysis of factors predicting resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. Korean J Pediatr 2016;59:80-90. https://doi.org/10.3345/kjp.2016.59.2.80
  20. Rhim JW, Youn YS, Han JW, Lee SJ, Oh JH, Lee KY. Changes in Kawasaki disease during 2 decades at a single institution in Daejeon, Korea. Pediatr Infect Dis J 2014;33:372-5. https://doi.org/10.1097/INF.0000000000000123

피인용 문헌

  1. Predictive risk factors of coronary artery aneurysms in Kawasaki disease vol.62, pp.4, 2019, https://doi.org/10.3345/kjp.2019.00073
  2. Oxidised Low-Density Lipoprotein and Its Receptor-Mediated Endothelial Dysfunction Are Associated with Coronary Artery Lesions in Kawasaki Disease vol.13, pp.2, 2019, https://doi.org/10.1007/s12265-019-09908-y
  3. Utility of color Doppler echocardiography combined with clinical markers in diagnosis and prediction of prognosis of coronary artery lesions in Kawasaki disease vol.19, pp.4, 2019, https://doi.org/10.3892/etm.2020.8519
  4. Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study vol.19, pp.1, 2019, https://doi.org/10.1186/s12969-021-00589-z